KoKo has reached an agreement to distribute Hong Kong-based Belun Technology’s system for monitoring Covid-19 patients’ vital signs in the US.
Called BLR-100C, the device remotely measures the patient’s vital signs, including oxygen saturation (SpO₂), pulse rate and temperature.
It will free up essential resources and reduce the exposure of medical and nursing home staff to the virus, the company noted.
Moreover, the device can be cleaned for unlimited re-use within its estimated three-year life cycle.
The BLR-100C system uses a SIM card, cloud-based system with HIPAA secure AWS protocols to transmit the patient’s Covid-19-related data to Belun Remote Monitoring Station. Clinicians will be able to view the data using a web-enabled computer, tablet or cell phone.
The system includes the Food and Drug Administration (FDA)-cleared Belun Ring that measures SpO₂ and pulse rate of the patients, while a disposable probe monitors body temperature.
Belun Technologies CEO Lydia Leung said: “We are very pleased to launch our BLR-100C system onto the USA healthcare market during the Covid-19 pandemic.
“Remote monitoring will free up essential resources and the need for frequent bedside visits to check on vitals, while home monitoring allows you to utilise beds for more critical patients.”
KoKo president and CEO John Peterson said: “We are honoured that Belun Technologies selected our company as its USA distributor for the BLR-100C system.
“The BLR-100C system will provide our customers with another tool in their care of patients with a life-threatening respiratory disease and will be an important addition to KoKo’s renowned devices for testing and monitoring of lung function.”
Headquartered in Longmont, KoKo is a respiratory information systems software developer and medical device manufacturer. The company is FDA-registered distributor of BLR-100C system for the US.